Gold drops as bets fade for big Fed rate cut fade; eyes on trade talks

By Karthika Suresh Namboothiri (Reuters) - Gold prices dipped on Wednesday on signals the U.S. Federal Reserve would not make too steep a cut to interest rates next month, but still held ground above the key psychological $1,400 level

Reuters June 27, 2019 01:09:07 IST
Gold drops as bets fade for big Fed rate cut fade; eyes on trade talks

Gold drops as bets fade for big Fed rate cut fade eyes on trade talks

By Karthika Suresh Namboothiri

(Reuters) - Gold prices dipped on Wednesday on signals the U.S. Federal Reserve would not make too steep a cut to interest rates next month, but still held ground above the key psychological $1,400 level.

Spot gold shed 0.8% to $1,411.21 per ounce as of 1:56 p.m. EDT (1756 GMT), having fallen more than 1% earlier in the session.

Gold is on track to snap a six-session streak of gains and also its biggest one day percentage fall in more than two weeks.

U.S. gold futures settled 0.2% lower to $1,415.40.

"In gold, people were looking for a reason to sell some just because over the past week and a half gold has gone up exponentially. It had that break down and then kept on running," said Michael Matousek, head trader at U.S. Global Investors.

"You're seeing people playing the volatility."

In the previous session, prices had hit a six-year peak of $1,438.63 primarily on the back of heightened expectations that the Fed, like many counterparts around the world, would cut rates in acknowledgment of tepid economic stimulus and weak data.

Fed Chairman Jerome Powell stressed the central bank's independence from U.S. President Donald Trump, who is pushing for rate cuts. St. Louis Fed President James Bullard, considered one of the most dovish U.S. central bankers, surprised some investors by saying a 50 basis point cut in rates "would be overdone."

Following the statements from the Fed officials, gold sapped gains and has dropped nearly 2.6%. Lower interest rates reduce the opportunity cost of holding non-yielding gold, prompting investors to sell some.

The comments by Powell and Bullard have assisted in "enabling the dollar to find some much-needed support and undermining buck-denominated precious metals," Fawad Razaqzada, market analyst with Forex.com, wrote in a note, adding that a rebound in equities on trade talk hopes between U.S. and China has further pressured gold.

Trump is expected to meet with Chinese leader Xi Jinping at the G20 summit in Japan, where he said there is a possibility a deal could be struck, omitting the need for imposing more tariffs on goods from China.

"As time goes on, there are more uncertainties and that's what is keeping gold prices above $1,400," said an analyst based in New York.

"Prices should hold and continue to trend higher, unless there is some resolution on (U.S.-China) trade issues."

Among other precious metals, silver fell 0.3% to $15.31 per ounce, while platinum rose 0.8% to $812.50. Spot palladium was 0.4% higher at $1,534.00 per ounce.

(Reporting by Karthika Suresh Namboothiri in Bengaluru; Editing by Nick Zieminski)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports
Business

Gilead nears deal to buy Immunomedics for more than $20 billion, WSJ reports

(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment

China bans German pork imports after African swine fever case
Business

China bans German pork imports after African swine fever case

SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.

Libya's Haftar committed to ending oil blockade, U.S. says
Business

Libya's Haftar committed to ending oil blockade, U.S. says

CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.